-FDA Agrees to Company Request to Change Primary Endpoint to Overall Survival-
-Previously Planned Interim Analysis Will Not Be Conducted-
-Management to Host Webcast / Conference Call Today at 5 p.m. ET / 2 p.m. PT-
PR Newswire
SAN DIEGO, Nov. 26, 2018